WPR.V
CanPR Technology Ltd.Loading price…
Loading price…
Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.
2 active warrant series covering 11,816,427 shares (~29.3% potential dilution); nearest expiry 2027-07-13.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.06 | Jul 13, 2027 284d | 11.8M | OTM | 29.2% | C$706K | Auto |
| warrant | $2.50 | Jun 3, 2031 1705d | 54K | OTM | 0.1% | C$135K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
9 option grants covering 3,706,546 shares (~9.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.40 | Jul 26, 2027 297d | 2.4M | OTM | 5.9% | C$944K | Auto |
| option | $0.48 | Aug 13, 2027 315d | 1.2M | OTM | 3.1% | C$594K | Auto |
| option | $0.02 | Jan 1, 2028 456d | 91K | ITM | 0.2% | C$2K | Auto |
| option | $0.67 | Nov 17, 2030 1507d | 5K | OTM | 0.0% | C$3K | Auto |
| option | $0.67 | Dec 7, 2030 1527d | 5K | OTM | 0.0% | C$3K | Auto |
| option | $0.48 | Feb 25, 2031 1607d | 7K | OTM | 0.0% | C$3K | Auto |
| option | $1.73 | Aug 25, 2031 1788d | 10 | OTM | 0.0% | C$17.3 | Auto |
| option | $1.73 | Nov 29, 2031 1884d | 500 | OTM | 0.0% | C$865 | Auto |
| option | $0.69 | Dec 20, 2031 1905d | 1K | OTM | 0.0% | C$690 | Auto |
40,327,916 shares outstanding, plus 11,816,427 from warrants and 3,706,546 from options — a fully diluted 55,850,889 shares, or ~38.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
2 active warrant series covering 11,816,427 shares (~29.3% potential dilution); nearest expiry 2027-07-13.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.06 | Jul 13, 2027 284d | 11.8M | OTM | 29.2% | C$706K | Auto |
| warrant | $2.50 | Jun 3, 2031 1705d | 54K | OTM | 0.1% | C$135K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
9 option grants covering 3,706,546 shares (~9.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.40 | Jul 26, 2027 297d | 2.4M | OTM | 5.9% | C$944K | Auto |
| option | $0.48 | Aug 13, 2027 315d | 1.2M | OTM | 3.1% | C$594K | Auto |
| option | $0.02 | Jan 1, 2028 456d | 91K | ITM | 0.2% | C$2K | Auto |
| option | $0.67 | Nov 17, 2030 1507d | 5K | OTM | 0.0% | C$3K | Auto |
| option | $0.67 | Dec 7, 2030 1527d | 5K | OTM | 0.0% | C$3K | Auto |
| option | $0.48 | Feb 25, 2031 1607d | 7K | OTM | 0.0% | C$3K | Auto |
| option | $1.73 | Aug 25, 2031 1788d | 10 | OTM | 0.0% | C$17.3 | Auto |
| option | $1.73 | Nov 29, 2031 1884d | 500 | OTM | 0.0% | C$865 | Auto |
| option | $0.69 | Dec 20, 2031 1905d | 1K | OTM | 0.0% | C$690 | Auto |
40,327,916 shares outstanding, plus 11,816,427 from warrants and 3,706,546 from options — a fully diluted 55,850,889 shares, or ~38.5% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.